XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common shares
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Total
Balance, beginning of period at Jan. 31, 2023 $ 538,448 $ 486,551 $ (30,456) $ 104,848  
Stock-based compensation expense (Note 16)   7,370      
Stock options and share units exercised 8,536 (7,401)      
Other comprehensive income (loss), net of income taxes     8,439    
Net income       57,469 $ 57,469
Balance, end of period at Jul. 31, 2023 546,984 486,520 (22,017) 162,317 1,173,804
Balance, beginning of period at Apr. 30, 2023 546,274 482,214 (30,452) 134,201  
Stock-based compensation expense (Note 16)   4,451      
Stock options and share units exercised 710 (145)      
Other comprehensive income (loss), net of income taxes     8,435    
Net income       28,116 28,116
Balance, end of period at Jul. 31, 2023 546,984 486,520 (22,017) 162,317 1,173,804
Balance, beginning of period at Jan. 31, 2024 551,164 494,701 (28,586) 220,755 1,238,034
Stock-based compensation expense (Note 16)   9,277      
Stock options and share units exercised 10,686 (9,918)      
Other comprehensive income (loss), net of income taxes     (5,663)    
Net income       69,348 69,348
Balance, end of period at Jul. 31, 2024 561,850 494,060 (34,249) 290,103 1,311,764
Balance, beginning of period at Apr. 30, 2024 557,741 489,378 (35,983) 255,422  
Stock-based compensation expense (Note 16)   5,508      
Stock options and share units exercised 4,109 (826)      
Other comprehensive income (loss), net of income taxes     1,734    
Net income       34,681 34,681
Balance, end of period at Jul. 31, 2024 $ 561,850 $ 494,060 $ (34,249) $ 290,103 $ 1,311,764